Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumours. gemcitabine-based regimens have been used as front-line treatments for patients with advanced pancreatic cancer. gemcitabine may initially show a response, but most often multi-drug resistance (MDR) rapidly develops...

Full description

Bibliographic Details
Main Author: Bugde, Piyush (Author)
Other Authors: Li, Yan (Contributor), Lu, Jun (Contributor), Merien, Fabrice (Contributor)
Format: Others
Published: Auckland University of Technology, 2019-07-16T23:09:08Z.
Online Access:Get fulltext